Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 70 /hr
Hire Dr. Margriet P.
USD 70 /hr

Expert in human health risk assessment of nanotechnology and medical technology

Profile Summary
Subject Matter Expertise
Work Experience

senior researcher

National Institute for Public Health and the Environment (RIVM)

October 2004 - Present

Rijksinstituut voor Volksgezondheid en Milieu

2004 - Present


Loders Croklaan Lipid Nutrition

February 2003 - September 2004

Research assistant

Michigan State University

September 2001 - October 2002


PhD in Nanotoxicology

Maastricht University

October 2007 - July 2011

PhD (Toxicogenomics)

Maastricht University

2007 - 2011

MSc Biology (Toxicology)

Wageningen Universiteit en Researchcentrum

1996 - 2001

International Baccalaureate

United World College of the Atlantic

September 1992 - June 1994

  • Certification details not provided.
(2019). Assessment of oxidative damage induced by iron oxide nanoparticles on different nervous system cells . Mutation Research - Genetic Toxicology and Environmental Mutagenesis. 845.
Halamoda-Kenzaoui, B., Baconnier, S., Bastogne, T., Bazile, D., Boisseau, P., Borchard, G., Borgos, S.E., Calzolai, L., Cederbrant, K., Di Felice, G., et al.(2019). Bridging communities in the field of nanomedicine . Regulatory Toxicology and Pharmacology. 106. p. 187-196.
(2017). Nanomedicinal products: A survey on specific toxicity and side effects . International Journal of Nanomedicine. 12. p. 6107-6129.
Park, M.V.D.Z., Bleeker, E.A.J., Brand, W., Cassee, F.R., Van Elk, M., Park, M.V.D.Z., Bleeker, E.A.J., Brand, W., Cassee, F.R., Van Elk, M., et al.(2017). Considerations for Safe Innovation: The Case of Graphene . ACS Nano. 11. (10). p. 9574-9593.
(2015). Progress and future of in vitro models to study translocation of nanoparticles . Archives of Toxicology. 89. (9). p. 1469-1495.
Hougaard, K.S., Campagnolo, L., Chavatte-Palmer, P., Hougaard, K.S., Hougaard, K.S., Campagnolo, L., Chavatte-Palmer, P., Tarrade, A., Rousseau-Ralliard, D., Valentino, S., et al.(2015). A perspective on the developmental toxicity of inhaled nanoparticles . Reproductive Toxicology. 56. p. 118-140.
(2015). A practical approach to determine dose metrics for nanomaterials . Environmental Toxicology and Chemistry. 34. (5). p. 1015-1022.
Park, M.V.D.Z., Verharen, H.W., Zwart, E., Hernandez, L.G., Van Benthem, J., Elsaesser, A., Barnes, C., McKerr, G., Howard, C.V., Salvati, A., et al.(2011). Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay . Nanotoxicology. 5. (2). p. 168-181.
Colognato, R., Park, M.V.D.Z., Wick, P., De Jong, W.H.(2012). Interactions with the Human Body . Adverse Effects of Engineered Nanomaterials. p. 3-24.